CSIMarket



Sangui Biotech International Inc  (SGBI)
Other Ticker:  
 
 

SGBI's Operating Income Growth by Quarter and Year

Sangui Biotech International Inc's Operating Income results by quarter and year




SGBI Operating Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter June - -0.04 -0.05 -0.11
III Quarter March -0.03 -0.03 -0.04 -0.07
II Quarter December -0.02 -0.04 -0.04 -0.06
I Quarter September -0.04 -0.04 -0.06 -0.09
FY   -0.09 -0.15 -0.19 -0.33



SGBI Operating Income third quarter 2022 Y/Y Growth Comment
Sangui Biotech International Inc in the third quarter 2022 recorded Operating Loss of $ -0.03 millions.

According to the results reported in the third quarter 2022, Sangui Biotech International Inc achieved the best Operating Income growth in Biotechnology & Pharmaceuticals industry. While Sangui Biotech International Inc' s Operating Income no change of % ranks overall at the positon no. in the third quarter 2022.

Explain Operating Income growth


SGBI Operating Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -
I Quarter September - - - -
FY   - - - -

Financial Statements
Sangui Biotech International Inc's third quarter 2022 Operating Income $ -0.03 millions SGBI's Income Statement
Sangui Biotech International Inc's third quarter 2021 Operating Income $ -0.03 millions Quarterly SGBI's Income Statement
New: More SGBI's historic Operating Income Growth >>


SGBI Operating Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -
I Quarter September - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Sangui Biotech International Inc's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SGBI's III. Quarter Q/Q Operating Income Comment
III. Quarter 2022 results of -0.03 millions by Sangui Biotech International Inc appear even less good compare to the -0.02 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry Sangui Biotech International Inc achieved highest sequential Operating Income growth. While Sangui Biotech International Inc's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SGBI's III. Quarter Q/Q Operating Income Comment
Current results of -0.03 millions by Sangui Biotech International Inc look even worse if you take a look at -0.02 millions a quarter before.

Within Biotechnology & Pharmaceuticals industry Sangui Biotech International Inc achieved highest sequential Operating Income growth. While Sangui Biotech International Inc's Operating Income growth quarter on quarter, overall rank is .


Sangui Biotech International Inc's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Operating Income 12 Months Ending $ -0.13 $ -0.13 $ -0.15 $ -0.15 $ -0.16
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment


Sangui Biotech International Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment


Sangui Biotech International Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Biotechnology & Pharmaceuticals Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
SGBI's Operating Income Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for SGBI's Competitors
Operating Income Growth for Sangui Biotech International Inc's Suppliers
Operating Income Growth for SGBI's Customers

You may also want to know
SGBI's Annual Growth Rates SGBI's Profitability Ratios SGBI's Asset Turnover Ratio SGBI's Dividend Growth
SGBI's Roe SGBI's Valuation Ratios SGBI's Financial Strength Ratios SGBI's Dividend Payout Ratio
SGBI's Roa SGBI's Inventory Turnover Ratio SGBI's Growth Rates SGBI's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Mar 31 2022
Lemaitre Vascular Inc-0.21%$ -0.214 millions
Intuitive Surgical Inc.-2.09%$ -2.087 millions
Innoviva Inc.-2.21%$ -2.207 millions
Stryker Corp-2.61%$ -2.614 millions
National Research Corporation-2.69%$ -2.687 millions
Diffusion Pharmaceuticals Inc -2.77%$ -2.773 millions
Msa Safety Inc-3.11%$ -3.111 millions
Nuvasive Inc-3.28%$ -3.282 millions
Royalty Pharma Plc-4.18%$ -4.178 millions
Phibro Animal Health Corp-4.66%$ -4.659 millions
Co diagnostics Inc.-4.94%$ -4.942 millions
National Healthcare Corp-6.60%$ -6.602 millions
Natus Medical Inc-7.50%$ -7.500 millions
Dexcom Inc.-10.02%$ -10.022 millions
Biomx Inc -10.20%$ -10.196 millions
Pacira Biosciences inc.-10.52%$ -10.516 millions
Align Technology inc.-12.14%$ -12.138 millions
Lifevantage Corp-12.60%$ -12.596 millions
Tivity Health Inc -12.86%$ -12.858 millions
Rackspace Technology Inc -13.64%$ -13.636 millions
Diversified Healthcare Trust-15.19%$ -15.194 millions
Petmed Express Inc.-15.86%$ -15.858 millions
Community Health Systems Inc.-17.18%$ -17.178 millions
Fonar Corporation-18.88%$ -18.878 millions
Universal Health Services Inc.-21.24%$ -21.244 millions
Molecular Templates Inc -21.64%$ -21.642 millions
Quest Diagnostics Inc-22.27%$ -22.273 millions
Davita Inc.-23.56%$ -23.564 millions
Fulgent Genetics Inc.-24.35%$ -24.348 millions
Zimmer Biomet Holdings Inc.-25.30%$ -25.301 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FF's Profile

Stock Price

FF's Financials

Business Description

Fundamentals

Charts & Quotes

FF's News

Suppliers

FF's Competitors

Customers & Markets

Economic Indicators

FF's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071